Honglan Wang

2.1k total citations
62 papers, 1.6k citations indexed

About

Honglan Wang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Honglan Wang has authored 62 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 10 papers in Oncology. Recurrent topics in Honglan Wang's work include Cardiac electrophysiology and arrhythmias (10 papers), Nanoparticle-Based Drug Delivery (9 papers) and Ion channel regulation and function (8 papers). Honglan Wang is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Nanoparticle-Based Drug Delivery (9 papers) and Ion channel regulation and function (8 papers). Honglan Wang collaborates with scholars based in China, United States and Hong Kong. Honglan Wang's co-authors include Mark T. Ziolo, Mark J. Kohr, Yong Zhao, Debra G. Wheeler, Theodore Mazzone, Mark T. Ziolo, Tingjie Yin, Meirong Huo, Lifei Tang and Christopher J. Traynham and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biomaterials.

In The Last Decade

Honglan Wang

59 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Honglan Wang China 25 733 427 295 228 227 62 1.6k
Shiyan Li China 26 685 0.9× 284 0.7× 227 0.8× 186 0.8× 210 0.9× 96 1.9k
Madhulika Dixit India 23 908 1.2× 163 0.4× 310 1.1× 128 0.6× 125 0.6× 47 1.9k
Chun Pan Taiwan 24 792 1.1× 188 0.4× 183 0.6× 77 0.3× 133 0.6× 100 1.9k
Fei Li China 29 1.0k 1.4× 237 0.6× 212 0.7× 76 0.3× 179 0.8× 112 2.4k
Gang Zhao China 30 762 1.0× 181 0.4× 179 0.6× 69 0.3× 110 0.5× 107 2.1k
Meenakshi Sundaram India 30 665 0.9× 313 0.7× 174 0.6× 99 0.4× 124 0.5× 94 2.2k
Yen‐Hui Chen Taiwan 30 1.1k 1.5× 216 0.5× 195 0.7× 59 0.3× 184 0.8× 61 2.1k
Xiong Chen China 23 939 1.3× 198 0.5× 241 0.8× 63 0.3× 73 0.3× 81 1.8k
Litai Jin China 23 1.0k 1.4× 168 0.4× 166 0.6× 66 0.3× 74 0.3× 81 1.8k

Countries citing papers authored by Honglan Wang

Since Specialization
Citations

This map shows the geographic impact of Honglan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honglan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honglan Wang more than expected).

Fields of papers citing papers by Honglan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honglan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honglan Wang. The network helps show where Honglan Wang may publish in the future.

Co-authorship network of co-authors of Honglan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Honglan Wang. A scholar is included among the top collaborators of Honglan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honglan Wang. Honglan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zihong, Liuping Wang, Peng Zhang, et al.. (2025). Andrographolide Sulfonates and Xiyanping: A Review of Chemical Composition, Pharmacological Activities, Clinical Applications, and Adverse Reactions. Pharmaceuticals. 18(2). 183–183. 3 indexed citations
2.
Zhang, Zhihong, Yang Gao, Yubei Chen, et al.. (2025). Structural and functional analysis of soy protein-skipjack tuna protein gels prepared by two-screw extrusion and their effects on metabolites and gut microbiota in vitro. Food Chemistry X. 27. 102466–102466. 1 indexed citations
4.
Zeng, Ping, Honglan Wang, Pengfei Zhang, & Sharon Shui Yee Leung. (2024). Unearthing naturally-occurring cyclic antibacterial peptides and their structural optimization strategies. Biotechnology Advances. 73. 108371–108371. 5 indexed citations
5.
Liu, Huiwen, Bo Zhang, Honglan Wang, et al.. (2024). Targeted Delivery of c(RGDfk)‐Modified Liposomes to Bone Marrow Through In Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy. Advanced Science. 12(12). e2409895–e2409895. 2 indexed citations
6.
Wang, Honglan, Yiwei Wang, Huiwen Liu, et al.. (2024). Ruxolitinib-loaded cytokine nanosponge alleviated the cytokine storm and dampened macrophage overactivation for the treatment of hemophagocytic lymphohistiocytosis. International Journal of Pharmaceutics. 657. 124127–124127. 2 indexed citations
7.
Liu, Huiwen, Honglan Wang, Qiyu Li, et al.. (2023). LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment. Acta Pharmaceutica Sinica B. 13(9). 3817–3833. 16 indexed citations
8.
Wang, Honglan, Huiwen Liu, Jia Li, et al.. (2022). Cytokine nanosponges suppressing overactive macrophages and dampening systematic cytokine storm for the treatment of hemophagocytic lymphohistiocytosis. Bioactive Materials. 21. 531–546. 24 indexed citations
9.
Liu, Chunying, Shuangrong Ruan, Xuejing Li, et al.. (2022). Broad-spectrum and powerful neutralization of bacterial toxins by erythroliposomes with the help of macrophage uptake and degradation. Acta Pharmaceutica Sinica B. 12(11). 4235–4248. 16 indexed citations
10.
Wang, Honglan, Huiwen Liu, Chunyan Sun, et al.. (2021). Nanoparticles Dual Targeting Both Myeloma Cells and Cancer-Associated Fibroblasts Simultaneously to Improve Multiple Myeloma Treatment. Pharmaceutics. 13(2). 274–274. 12 indexed citations
12.
Xu, Yuanxin, et al.. (2021). Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas. Acta Pharmaceutica Sinica B. 12(3). 1100–1125. 33 indexed citations
14.
Song, Xiang, Wei Hu, Haibo Yu, et al.. (2020). Existence of Circulating Mitochondria in Human and Animal Peripheral Blood. International Journal of Molecular Sciences. 21(6). 2122–2122. 49 indexed citations
15.
Wang, Ruoning, Yujie Yang, Mengmeng Yang, et al.. (2020). Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein/DOX nanodispersions. Journal of Nanobiotechnology. 18(1). 116–116. 37 indexed citations
16.
Wang, Ruoning, et al.. (2020). Impacts of particle size on the cytotoxicity, cellular internalization, pharmacokinetics and biodistribution of betulinic acid nanosuspensions in combined chemotherapy. International Journal of Pharmaceutics. 588. 119799–119799. 24 indexed citations
17.
Zhao, Pei, et al.. (2019). Does Biochar Amendment Influence Water Uptake Pattern of Winter Wheat (Triticum aestivum)? A Case Study in a Shallow Entisol. International Journal of Agriculture and Biology. 24(4). 935–944. 1 indexed citations
18.
Wang, Ming, Hongxia Cui, Chao Sun, et al.. (2016). [Effect of lupeol on migration and invasion of human breast cancer MDA-MB-231 cells and its mechanism].. PubMed. 51(4). 558–62. 11 indexed citations
20.
Wang, Honglan, Jie Gao, Danni Zhu, & Boyang Yu. (2006). Quality evaluation of Polygala japonica through simultaneous determination of six bioactive triterpenoid saponins by HPLC-ELSD. Journal of Pharmaceutical and Biomedical Analysis. 43(4). 1552–1556. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026